Enanta Pharmaceuticals Inc Working Capital to Net Assets Ratio
Enanta Pharmaceuticals Inc working capital to net assets ratio. Enanta Pharmaceuticals Inc (ENTA) has a Working Capital to Net Assets ratio of 147.9% as of June 2026. Working capital of $149.45 Million (current assets of $203.62 Million minus current liabilities of $54.17 Million) is measured against net assets of $101.07 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check ENTA intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Enanta Pharmaceuticals Inc (2011–2025)
Working capital to net assets ratio of Enanta Pharmaceuticals Inc from 2011 to 2025. This chart shows how Enanta Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of June 2026, the ratio stands at 147.9%, reflecting working capital of $149.45 Million against net assets of $101.07 Million USD. See Enanta Pharmaceuticals Inc (ENTA) defensive interval to measure how many days the company can operate on defensive assets alone.
Enanta Pharmaceuticals Inc Working Capital to Net Assets Ratio by Year (2011–2025)
Enanta Pharmaceuticals Inc working capital to net assets ratio by year from 2011 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Enanta Pharmaceuticals Inc from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Enanta Pharmaceuticals Inc.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 240.7% | $155.78 Million | $64.72 Million | $204.34 Million | $48.55 Million | ▲ +52.6 pp |
| 2024 | 188.1% | $242.32 Million | $128.81 Million | $299.85 Million | $57.53 Million | ▲ +22.0 pp |
| 2023 | 166.1% | $360.00 Million | $216.74 Million | $422.79 Million | $62.79 Million | ▲ +78.4 pp |
| 2022 | 87.7% | $281.89 Million | $321.33 Million | $311.71 Million | $29.83 Million | ▲ +16.9 pp |
| 2021 | 70.8% | $282.85 Million | $399.43 Million | $319.02 Million | $36.17 Million | ▼ -19.8 pp |
| 2020 | 90.6% | $412.68 Million | $455.58 Million | $436.84 Million | $24.16 Million | ▲ +8.6 pp |
| 2019 | 82.0% | $379.24 Million | $462.49 Million | $401.85 Million | $22.61 Million | ▼ -10.6 pp |
| 2018 | 92.6% | $364.36 Million | $393.68 Million | $380.39 Million | $16.02 Million | ▲ +20.7 pp |
| 2017 | 71.9% | $216.84 Million | $301.68 Million | $237.82 Million | $20.98 Million | ▼ -11.2 pp |
| 2016 | 83.1% | $224.27 Million | $269.94 Million | $232.16 Million | $7.89 Million | ▲ +13.7 pp |
| 2015 | 69.4% | $163.94 Million | $236.16 Million | $170.64 Million | $6.70 Million | ▼ 0.0 pp |
| 2014 | 69.4% | $103.23 Million | $148.65 Million | $107.97 Million | $4.75 Million | ▼ -21.3 pp |
| 2013 | 90.7% | $100.19 Million | $110.47 Million | $104.71 Million | $4.53 Million | ▼ -3.9 pp |
| 2012 | 94.6% | $41.57 Million | $43.93 Million | $47.31 Million | $5.73 Million | ▲ +112.0 pp |
| 2011 | -17.4% | $22.95 Million | $-131.96 Million | $25.10 Million | $2.15 Million | — |